PORTLAND, Oregon, February 5, 2015 /PRNewswire/ --
TechNavio's analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market.
Further Details of this Report @http://www.reportsandintelligence.com/global-biosimilars-2014-2018-market
TechNavio's report, the Global Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Biocon Ltd., Hospira Inc., Mylan Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and Celltrion Inc.
Other vendors mentioned in the report are Actavis plc, Amgen Inc., AstraZeneca plc, Baxter International Inc., Biogen Idec Inc., Bioton S.A., Boehringer Ingelheim GmbH, Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Emcure Pharmaceuticals Ltd., GE Healthcare Ltd., GeneScience Pharmaceuticals Co. Ltd., GlaxoSmithKline plc, JCR Pharmaceuticals Co. Ltd., iBio Inc., LG Life Sciences Co. Ltd., Merck & Co. Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Samsung Biologics Co. Ltd., Sanofi S.A., and Wockhardt Ltd.
Key questions answered in this report:
What will the market size be in 2016/2018 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
Inquiry Before Buying -http://www.reportsandintelligence.com/enquire-about-report/17682
Similar Market Studies
Global Liver Diseases Therapeutics Market (Disease types, Therapeutics, Drug class and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 Liver diseases are one of the most prevalent diseases in the world. The commercialization of variety of liver therapeutics drugs has made the treatment of these diseases possible.
http://www.reportsandintelligence.com/liver-diseases-therapeutics-market
Cigna-HealthSpring: Company Profile and SWOT Analysis World Market Intelligence's "Cigna-HealthSpring: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries as well as employee biographies.
http://www.reportsandintelligence.com/cigna-healthspring-company-profile-and-swot-analysis-market
Active Pharmaceutical Ingredients (API) Market in India 2015-2019 Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.
http://www.reportsandintelligence.com/active-pharmaceutical-ingredients-api-in-india-2015-2019-market
About Us:
Reports and Intelligence is an online library for research reports in numerous sectors and their verticals. This is the one stop destination for well researched reports with exact market analysis.
Contact Us:
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct:+1-(617)-674-4143
Toll Free: +1-(855)-711-1555
Fax: +1-(855)-550-5975
Email Id: help@reportsandintelligence.com
Linkedin:https://www.linkedin.com/company/reports-and-intelligence
Twitter:https://twitter.com/RNIntelligence
